Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Leuti

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|May 11, 2017
TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in miceMaria Cristina Marrone, Annunziato Morabito, Michela Giustizieri, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 10, 2024
Protective effects of fatty acid amide hydrolase inhibition in UVB-activated microgliaVeronica Carnicelli, Noemi De Dominicis, Lucia Scipioni, et al.
Cell Reports|June 2, 2021
Pro-resolving lipid mediator lipoxin A<sub>4</sub> attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidomeClaudio Derada Troletti, Gaby Enzmann, Valerio Chiurchiù, et al.
Haematologica|November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunctionGijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.
Nature Communications|September 4, 2019
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Nature Communications|October 16, 2019
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Frontiers in Immunology|May 8, 2023
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profilesLuca Navarini, Marta Vomero, Damiano Currado, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|May 11, 2017
TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in miceMaria Cristina Marrone, Annunziato Morabito, Michela Giustizieri, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 10, 2024
Protective effects of fatty acid amide hydrolase inhibition in UVB-activated microgliaVeronica Carnicelli, Noemi De Dominicis, Lucia Scipioni, et al.
Cell Reports|June 2, 2021
Pro-resolving lipid mediator lipoxin A<sub>4</sub> attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidomeClaudio Derada Troletti, Gaby Enzmann, Valerio Chiurchiù, et al.
Haematologica|November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunctionGijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.
Nature Communications|September 4, 2019
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Nature Communications|October 16, 2019
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Frontiers in Immunology|May 8, 2023
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profilesLuca Navarini, Marta Vomero, Damiano Currado, et al.
Pageof 4